Bharat Biotech International Limited

CISF takes over security of Covaxin manufacturer Bharat Biotech's Hyderabad Facility   - Sakshi Post
Jun 15, 2021
HYDERABAD:  The Central Industrial Security Force (CISF)  will now be providing security for vaccine manufacturer Bharat Biotech's premises in Hyderabad from Monday to protect it against any terror...
 - Sakshi Post
May 14, 2021
Hyderabad: Serum and Bharat Biotech have announced that the production of their vaccines will be increased by August. They have also sent their four-month production schedule to the Centre.
COVID Nasal vaccine By Bharat Biotech - Sakshi Post
Mar 05, 2021
Dr Krishan Ella's Bharat Biotech has started the process of screening potential clinical trial participants at four centres in India - Nagpur, Hyderabad, Patna and Chennai for their new nasal vaccine...
 - Sakshi Post
Jan 27, 2021
Covaxin - vaccine developed by Hyderabad-based Bharat Biotech is said to be effective against UK variants of COVID-19, according to a study titled ''Neutralization of UK-variant VUI-202012/01 with...
 - Sakshi Post
Jan 03, 2021
NEW DELHI: With India's drugs regulator approving the  Oxford COVID-19 vaccine Covishield and Covaxin of Bharat Biotech, Dr Union Minister for Health & Family Welfare,  called it a," watershed...
 - Sakshi Post
Jul 05, 2020
HYDERABAD: The Hyderabad's Nizam’s Institute of Medical Sciences (NIMS) which was chosen for human clinical trials for COVID-19 vaccine, is all set to start clinical trials of BBV152 COVID vaccine...
 - Sakshi Post
Jul 03, 2020
HYDERABAD: India's first indigenous COVID-19 vaccine COVAXIN is expected to be launched by August 15 on Independence Day.
Back to Top